Taku Murata

Tsu, 5148507, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Development of micro-sequestra and associated histological changes in tooth extraction sockets of zoledronate-treated mice.

Development of micro-sequestra and associated histological changes in tooth extraction sockets of zoledronate-treated mice.

Journal: Journal of oral biosciences

Published: September 16, 2025

Novel Histopathological Findings of Micro Bone Fragments and Epithelial Response in the Oral Mucosa in Bisphosphonate-Related Osteonecrosis of the Jaw.

Novel Histopathological Findings of Micro Bone Fragments and Epithelial Response in the Oral Mucosa in Bisphosphonate-Related Osteonecrosis of the Jaw.

Journal: Journal of investigative medicine high impact case reports

Published: May 31, 2024

Predictive Value of Neutrophil-Lymphocyte Ratio as a Marker in Antiresorptive Agent-Related Osteonecrosis of the Jaw: A Retrospective Analysis.

Predictive Value of Neutrophil-Lymphocyte Ratio as a Marker in Antiresorptive Agent-Related Osteonecrosis of the Jaw: A Retrospective Analysis.

Journal: Diagnostics (Basel, Switzerland)

Published: June 24, 2022

Role of Phosphodiesterase2A in Proliferation and Migration of Human Osteosarcoma Cells.

Role of Phosphodiesterase2A in Proliferation and Migration of Human Osteosarcoma Cells.

Journal: Anticancer research

Published: September 17, 2019

Evaluation of a New Hydroxyapatite Nanoparticle as a Drug Delivery System to Oral Squamous Cell Carcinoma Cells.

Evaluation of a New Hydroxyapatite Nanoparticle as a Drug Delivery System to Oral Squamous Cell Carcinoma Cells.

Journal: Anticancer research

Published: October 16, 2018

Role of phosphodiesterase 2 in growth and invasion of human malignant melanoma cells.

Role of phosphodiesterase 2 in growth and invasion of human malignant melanoma cells.

Journal: Cellular signalling

Published: February 26, 2014

Characterization of phosphodiesterase 2A in human malignant melanoma PMP cells.

Characterization of phosphodiesterase 2A in human malignant melanoma PMP cells.

Journal: Oncology reports

Published: October 09, 2012

Phosphodiesterase 4 regulates the migration of B16-F10 melanoma cells.

Phosphodiesterase 4 regulates the migration of B16-F10 melanoma cells.

Journal: Experimental and therapeutic medicine

Published: March 23, 2012

Expression and role of phosphodiesterase 5 in human malignant melanoma cell line.

Expression and role of phosphodiesterase 5 in human malignant melanoma cell line.

Journal: Anticancer research

Published: March 25, 2010

Phosphodiesterase 3 (PDE3): structure, localization and function.

Phosphodiesterase 3 (PDE3): structure, localization and function.

Journal: Cardiovascular & hematological agents in medicinal chemistry

Published: August 20, 2009

Effect of the phosphodiesterase 4 inhibitor, rolipram, on retinoic acid-increased alkaline phosphatase activity in the mouse fibroblastic C3H10T1/2 cell line.

Effect of the phosphodiesterase 4 inhibitor, rolipram, on retinoic acid-increased alkaline phosphatase activity in the mouse fibroblastic C3H10T1/2 cell line.

Journal: Archives of oral biology

Published: March 05, 2003

Characterization of phosphodiesterase 3 in human malignant melanoma cell line.

Characterization of phosphodiesterase 3 in human malignant melanoma cell line.

Journal: Anticancer research

Published: January 18, 2003

Showing 1-12 of 15

Last Updated: 09/26/2026